AlphaProtein Novo: Google DeepMind’s Pipeline Designs Enzymes For Reactions Nature Never Evolved
Google DeepMind has introduced AlphaProtein Novo (AP Novo), a machine-learning pipeline for de novo enzyme design that, according to a preprint published on bioRxiv this week, demonstrates for the first time that computationally designed enzymes can outperform natural sequence mining on challenging chemistry. Developed jointly with Caltech and the University of Pittsburgh, the system designs enzymes from first principles rather than optimizing existing proteins, addressing a long-standing bottleneck in biocatalyst discovery.
The pipeline operates through motif scaffolding: a diffusion model co-generates protein structures and amino acid sequences around a catalytic motif — the arrangement of side chains and ligands required for a hypothesized reaction mechanism. Candidate designs are then filtered using metrics derived from AlphaFold 3 predictions, which assess mechanistically relevant atomic details such as the geometry between a catalytic base and its substrate. In total, the team tested more than 5,600 designs across five reactions, reporting hit rates of up to 80% in the best design facets and state-of-the-art catalytic efficiencies on benchmark reactions without iterative experimental optimization.
The headline applications illustrate the breadth of the approach. First, researchers designed nitrene transferases to synthesize piperidines — a heterocycle present in numerous FDA-approved drugs. The competitive cyclization of a substrate can yield either five-membered pyrrolidine or six-membered piperidine rings, and natural heme enzymes strongly favor the former. Screening 188 natural and engineered variants produced no enzyme exceeding a 30:70 piperidine-to-pyrrolidine ratio. By contrast, the lead de novo design, GDM_NT_270, achieved 99:1 regioselectivity for piperidine with 94% enantiomeric excess and 22 turnovers — inverting the natural bias by direct control over active-site geometry.
Second, the team targeted di(2-ethylhexyl)phthalate (DEHP), a pervasive plasticizer and endocrine-disrupting environmental contaminant whose bulky side chains and water insolubility defeat most natural hydrolases. A recent screen of 65 natural esterases found only one active DEHPase; AP Novo yielded seven new structural families capable of the reaction, with a novel-scaffold hit rate reaching 11% (39% for recycled scaffolds). Though currently less active than natural enzymes in aqueous conditions, the designs exhibit properties rare in nature: one 191-residue enzyme was 14-fold more active at 90°C than at room temperature and remained functional in 75% acetonitrile, conditions that fully denature natural esterases. Its small size and high expression in E. coli also reduce production costs.
Sequence Ensembles as the Key Signal
The work’s principal methodological insight concerns filtering. The researchers found that evaluating ensembles of LigandMPNN-derived sequences against the same backbone — requiring every resequenced variant to pass mechanism-inspired filters — dramatically amplified predictive power, raising serine esterase hit rates up to 30-fold. Combining this with partial-diffusion re-sampling of the backbone pushed retrospective hit rates to 60% for Kemp eliminases and 80% for serine esterases. The authors argue this explains why iterative redesign pipelines work: they implicitly select for backbones whose local sequence-structure space broadly supports the intended catalytic geometry.
Limitations remain. Catalytic activities are still orders of magnitude below natural or directed-evolution-optimized enzymes, motif construction demands reaction-specific expertise, and the models do not yet meaningfully capture the physics of catalysis. Nonetheless, with code and weights released for non-commercial use, AP Novo signals that generative protein design is becoming a practical complement — and in select cases an alternative — to mining natural biodiversity.
Disclaimer
In line with the Trust Project guidelines, please note that the information provided on this page is not intended to be and should not be interpreted as legal, tax, investment, financial, or any other form of advice. It is important to only invest what you can afford to lose and to seek independent financial advice if you have any doubts. For further information, we suggest referring to the terms and conditions as well as the help and support pages provided by the issuer or advertiser. MetaversePost is committed to accurate, unbiased reporting, but market conditions are subject to change without notice.
About The Author
Alisa, a dedicated journalist at the MPost, specializes in crypto, AI, investments, and the expansive realm of Web3. With a keen eye for emerging trends and technologies, she delivers comprehensive coverage to inform and engage readers in the ever-evolving landscape of digital finance.
More articles
Alisa, a dedicated journalist at the MPost, specializes in crypto, AI, investments, and the expansive realm of Web3. With a keen eye for emerging trends and technologies, she delivers comprehensive coverage to inform and engage readers in the ever-evolving landscape of digital finance.
